Shell Midstream Partners (NYSE:SHLX) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.38 by 13.16 percent. This is a 8.33 percent decrease over earnings of $0.36 per share from the same period last year.
Seagen Inc. Announces New Data For ADCETRIS With Immunotherapy Combination In Hodgkin Lymphoma To Be Featured At 2023 ASH Annual Meeting, And Seagen To Unveil Novel CD30-Directed Antibody-Drug Conjugate
– Updated Phase 2 data for ADCETRIS in combination with nivolumab in early and advanced stage classical Hodgkin lymphoma to be presented in oral session –– First preclinical data for investigational antibody-drug
